HRT Financial’s Tenax Therapeutics TENX Stock Holding History

HRT Financial’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$668K	Buy	+41,819	New	+$566K	﹤0.01%	2324
2024 Q1	–	Sell	-260	Closed	-$5K	–	3074
2023 Q4	$5K	Buy	+260	New	+$6.24K	﹤0.01%	2133
2023 Q3	–	Sell	-145	Closed	-$3K	–	3084
2023 Q2	$3K	Buy	+145	New	+$3.87K	﹤0.01%	2266
2023 Q1	–	Sell	-16	Closed	-$2K	–	3184
2022 Q4	$2K	Buy	16 +5	+45%	+$1.1K	﹤0.01%	2335
2022 Q3	$2K	Buy	+11	New	+$4.41K	﹤0.01%	2652
2022 Q2	–	Sell	-7	Closed	-$8K	–	3714
2022 Q1	$8K	Sell	7 -1	-13%	-$1.11K	﹤0.01%	2919
2021 Q4	$13K	Buy	+8	New	+$18K	﹤0.01%	2999
2020 Q3	–	Sell	-13	Closed	-$18K	–	2337
2020 Q2	$18K	Buy	+13	New	+$19.1K	﹤0.01%	1433

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HRT Financial's TENX Position: Q1 2026 in Review

HRT Financial opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 41,819 shares worth $668K. The stake represents ﹤0.01% of the portfolio and ranks #2324 among its holdings. This is a return to the name: HRT Financial previously reported a position in TENX as recently as Q4 2023.

HRT Financial first reported a position in TENX in Q2 2020 and has held it in 8 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

HRT Financial held 41,819 shares of Tenax Therapeutics worth $668K as of Q1 2026.
Tenax Therapeutics was a new HRT Financial position in Q1 2026.
Tenax Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2324 holding.
HRT Financial first reported a position in Tenax Therapeutics in Q2 2020 and has held it in 8 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.